CQS (US), LLC - VANECK VECTORS ETF TR ownership

VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.

Quarter-by-quarter ownership
CQS (US), LLC ownership history of VANECK VECTORS ETF TR
ValueSharesWeighting
Q3 2023$31,237,478
-10.6%
1,160,8130.0%3.12%
-25.7%
Q2 2023$34,952,079
+81.3%
1,160,813
+94.8%
4.20%
+75.3%
Q1 2023$19,274,551
+7.8%
595,813
-4.5%
2.40%
+2.3%
Q4 2022$17,886,505
+18.8%
624,0930.0%2.34%
+34.0%
Q3 2022$15,053,000
-70.6%
624,093
-66.7%
1.75%
-4.7%
Q2 2022$51,261,000
+114.2%
1,872,279
+200.0%
1.84%
+11.0%
Q1 2022$23,934,000
+19.7%
624,0930.0%1.66%
+31.9%
Q4 2021$19,990,000
+58.1%
624,093
+45.4%
1.26%
+73.6%
Q3 2021$12,646,000
-12.8%
429,093
+0.6%
0.72%
-10.3%
Q2 2021$14,500,000
+85.1%
426,717
+113.4%
0.81%
-22.2%
Q3 2020$7,832,000
-45.2%
200,000
-48.7%
1.04%
+18.7%
Q2 2020$14,286,000
+327.6%
389,500
+168.6%
0.87%
+254.9%
Q1 2020$3,341,000
-20.2%
145,000
+1.4%
0.25%
+25.5%
Q4 2019$4,187,000143,0000.20%
Other shareholders
VANECK VECTORS ETF TR shareholders Q2 2022
NameSharesValueWeighting ↓
New Harbor Financial Group, LLC 1,221,955$36,011,00014.81%
New Harbor Financial Group, LLC 1,155,900$34,064,00014.01%
Memorial Sloan Kettering Cancer Center 738,500$21,764,00013.56%
Hollow Brook Wealth Management LLC 670,275$19,753,00012.24%
Grand Central Investment Group 293,243$8,642,00011.46%
BW Gestao de Investimentos Ltda. 940,800$27,725,0008.44%
Slate Path Capital LP 5,930,000$174,757,0007.97%
Nokomis Capital, L.L.C. 512,628$15,107,0007.14%
Plaisance Capital LLC 288,000$8,487,0006.05%
Guild Investment Management, Inc. 200,114$5,897,0005.68%
View complete list of VANECK VECTORS ETF TR shareholders